Essential Pharma, an international pharmaceutical generics company dedicated to supplying well-established, “at risk” products to patients across multiple therapeutic areas, announces the appointment of Paul Heath as Deputy Chief Operating Officer.
Paul brings more than 20 years of experience in operational and supply chain excellence in complex regulatory environments across multiple pharmaceutical, healthcare and consumer categories.
Prior to joining Essential Pharma, Paul was Head of New Technology at GlaxoSmithKline (GSK). In this position he led a global, cross-functional technical innovation programme, which included end-to-end supply chain management and R&D functions across multiple geographies. During his more than 18-year career at GSK, he held a number of senior roles leading global supply chain activities and managing operational and manufacturing excellence.
At Essential Pharma, Paul will use his deep experience in operational excellence to focus particularly on supply chain management and improvement of products and processes as the company grows and expands significantly over the next few years.
Paul Heath said:
“I am excited to be joining the team at Essential Pharma to help deliver the Company’s ambitious growth strategy, which is focused on expanding its product portfolio and international reach. I am confident my experience will allow me to play an important role in scaling and further optimizing the supply chain activities needed to deliver Essential Pharma’s strategic goals.”